Literature DB >> 11313665

The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function.

C Donaldson1, P Denning-Kendall, B Bradley, J Hows.   

Abstract

Expansion of haemopoietic stem cells is proposed to combat graft failure in adult recipients following cord blood (CB) transplantation. Cultures are traditionally performed in medium containing FCS, but to transfer expansion to the clinic, 'good manufacturing practice' (GMP) standards are required. This study evaluated expansion cultures in culture bags and serum-free (SF) conditions, to comply with GMP, by analysing sub-populations of CD34(+) cells, colony-forming cells (CFC) and long-term culture initiating cells (LTC-IC). CD34(+)cell analysis has previously been used to measure clonogenic capacity and the CD34(+)CD38(neg) surface phenotype to measure primitive cell numbers. In this study, comparison of expansion in serum-replete medium with that in SF conditions demonstrated a lack of expression of CD38 on CD34(+) cells in the absence of serum. These findings must be considered in clinical studies using in vitro expansion in SF conditions, and the CD34(+)CD38(neg) phenotype should not be used to confirm maintenance, or expansion, of primitive progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11313665     DOI: 10.1038/sj.bmt.1702810

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

1.  Surface-immobilization of adhesion peptides on substrate for ex vivo expansion of cryopreserved umbilical cord blood CD34+ cells.

Authors:  Xue-Song Jiang; Chou Chai; Yue Zhang; Ren-Xi Zhuo; Hai-Quan Mao; Kam W Leong
Journal:  Biomaterials       Date:  2006-01-10       Impact factor: 12.479

2.  What is the future for cord blood stem cells?

Authors:  E A de Wynter
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

3.  Hematopoietic stem cells in research and clinical applications: The "CD34 issue".

Authors:  Zoran Ivanovic
Journal:  World J Stem Cells       Date:  2010-04-26       Impact factor: 5.326

4.  Manufacturing a Bone Marrow-On-A-Chip Using Maskless Photolithography.

Authors:  Benoit Souquet; Matthieu Opitz; Benoit Vianay; Stéphane Brunet; Manuel Théry
Journal:  Methods Mol Biol       Date:  2021

5.  Microtubules control nuclear shape and gene expression during early stages of hematopoietic differentiation.

Authors:  Stefan Biedzinski; Gökçe Agsu; Benoit Vianay; Marc Delord; Laurent Blanchoin; Jerome Larghero; Lionel Faivre; Manuel Théry; Stéphane Brunet
Journal:  EMBO J       Date:  2020-10-22       Impact factor: 11.598

6.  Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion.

Authors:  Kathryn Futrega; Kerry Atkinson; William B Lott; Michael R Doran
Journal:  Tissue Eng Part C Methods       Date:  2017-04       Impact factor: 3.056

7.  Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells.

Authors:  Michelle Millington; Allison Arndt; Maureen Boyd; Tanya Applegate; Sylvie Shen
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

8.  Implication of early lymphocyte recovery after allogeneic hematopoietic stem cell transplantation in children with leukemia.

Authors:  Dong Kyun Han; Hee Jo Baek; So Yeon Kim; Tai Ju Hwang; Hoon Kook
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.